Physician profile
Donna L Bostick
NPI 1144245622
$800.52
in general payments reported to CMS, 2019-2025
18 companies · $245 in 2025
The $245 reported for 2025 was more than what 85% of Advanced Practice Midwife providers received nationally (typical 2025 total: $70.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $201 · 2022: $128 · 2023: $138 · 2024: $88.83 · 2025: $245.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $472.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $471.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $108.26 | 2022-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $99.62 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $90.63 | 2022-2025 | |
| Agile Therapeutics, INC. | $83.33 | 2021-2023 | Twirla |
| Shield Therapeutics INC | $61.50 | 2022-2023 | Accrufer |
| Exact Sciences Corporation | $46.40 | 2023-2024 | Cologuard Collection Kit |
| Mylan Pharmaceuticals INC. | $45.73 | 2021-2022 | |
| Coopersurgical, INC. | $44.03 | 2024-2025 | Paragard T 380a |
| Exeltis, USA INC. | $38.56 | 2024-2025 | Slynd |
| Organon LLC | $33.14 | 2025 | Nexplanon |
| Supernus Pharmaceuticals, INC. | $24.31 | 2025 | Qelbree |
| Sage Therapeutics, LLC | $24.31 | 2025 | Zurzuvae |
| Daiichi Sankyo INC. | $23.30 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.62 | 2025 | |
| Merck Sharp & Dohme LLC | $17.58 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $14.10 | 2021 | |
| Hologic Sales and Service, LLC | $13.21 | 2021 | |
| Therapeuticsmd, INC. | $12.89 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donna Bostick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.